Skip to content

Lidocaine VS Hemodynamic, Metabolic and Hormonal Response

The Effect of Intravenous Lidocaine Infusion on Hemodynamic Reaction to Tracheal Intubation, as Well as Metabolic and Hormonal Response to Laparoscopic Procedure in Children: a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05238506
Enrollment
132
Registered
2022-02-14
Start date
2022-03-12
Completion date
2023-08-08
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Response, Acute Appendicitis, Complication of Treatment, Opioid Consumption, Pneumoperitoneum

Keywords

multimodal analgesia, lidocaine, intravenous lidocaine, laparoscopic appendectomy, children, pediatric population, adjuvant, metabolic stress response, hormonal response

Brief summary

Intravenous lidocaine - a potent local anesthetic with analgesic and anti- inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study has been planned to evaluate the efficacy of continuous intravenous infusion of lidocaine in alleviation of hemodynamic reaction to tracheal intubation, as well as metabolic and hormonal response to laparoscopic procedure in children.

Detailed description

Laryngoscopy and endotracheal intubation are associated with noxious stimulation. Exacerbated circulatory system response may present as hypertension or arrhythmias including cardiac arrest. A sudden change in hemodynamic status connected with painful stimulation may precipitate deterioration in cerebral blood flow, especially in patients with intracranial hypertension (traumatic brain injury, intracranial hemorrhage, active hydrocephalus, etc). Many interventions have been applied to attenuate harmful hemodynamic reaction. One of them is intravenous lidocaine infusion. According to available data lidocaine is superior to placebo in attenuating systolic, diastolic and mean arterial pressure changes in children. Our study will focus on assessing hemodynamic stability preserving properties during induction of anesthesia and tracheal intubation. Blood pressure will be recorded and analyzed. The secondary aim is to examine intravenous lidocaine infusion in terms of reducing systemic response to surgical stress. Cortisol and glucose levels will be measured before skin incision, and immediately after the end of surgery. Side effects and serum lidocaine levels will be recorded to determine safety of the examined intervention. Similar pattern of infusion was investigated in RCT concerning children population - the toxic plasma level of 5 mcg/ml was not reached. Studies on children population have promising results but high quality randomized controlled trials are still missing. The proposed study has been planned to evaluate the efficacy of continuous infusion of lidocaine as an adjunct to standard general anesthesia (involving intravenous induction and opioid with sevoflurane maintenance) in attenuating hemodynamic reaction to tracheal intubation, as well as metabolic and hormonal response to surgical procedure in children undergoing laparoscopic appendectomy.

Interventions

Intraoperative intravenous lidocaine infusion.

Intraoperative intravenous normal saline infusion.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The drug or placebo(normal saline) will be placed in a syringe by the principal investigator. Only principal investigator will be aware of the participants allocation. The principal investigator will not be involved in the process of: recruitment, providing an intervention, or outcomes assessment.

Eligibility

Sex/Gender
ALL
Age
18 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* ASA physical status class 1E, 2E, 3E; * Patients undergoing laparoscopic appendectomy.

Exclusion criteria

* Allergy to local anesthetics or contraindications for the use of lidocaine; * ASA physical status class 4E or higher; * Severe cardiovascular disease; * Preoperative bradycardia; * Preoperative atrioventricular block; * Renal failure; * Chronic treatment with analgesics; * Legal guardians' refusal.

Design outcomes

Primary

MeasureTime frameDescription
Hemodynamic reaction to tracheal intubationBefore intubation - immediately after intubation.A change in arterial blood pressure more than 20% from baseline. The fractions of patients in each group will be compared.

Secondary

MeasureTime frameDescription
Metabolic response to laparoscopic procedureFirst blood sample will be taken 5 minutes after tracheal intubation. Second blood sample will be taken just before extubation.Glucose \[mg/dl\] levels will be measured and compared before and after laparoscopic procedure.
Lidocaine blood levelFirst blood sample will be taken 5 minutes after tracheal intubation. Second blood sample will be taken just before extubation.Lidocaine level \[mcg/ml\] will be measured after initial bolus and just before the end of its infusion.
Side effects of lidocaineFrom the beginning of drug infusion until transfer to the postanesthesia care unit (10 minutes after extubation).Side effects of lidocaine will be assessed by recording the rates of the following complications: arrythmia, hypotension (defined as \<70th percentile for age), allergic reaction.
Hormonal response to laparoscopic procedureFirst blood sample will be taken 5 minutes after tracheal intubation. Second blood sample will be taken just before extubation.Cortisol levels \[mcg/dl\] will be measured and compared before and after laparoscopic procedure.

Other

MeasureTime frameDescription
The requirement for opioids during anesthesiaFrom the induction of anesthesia through to postanesthesia care unit admission (10 minutes after extubation).Total amount of fentanyl in micrograms per kilogram body weight used during anesthesia.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026